Gastric inhibitory polypeptide

GIP
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesGIP, gastric inhibitory polypeptide
External IDsOMIM: 137240; MGI: 107504; HomoloGene: 3043; GeneCards: GIP; OMA:GIP - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_004123

NM_008119

RefSeq (protein)

NP_004114

NP_032145

Location (UCSC)Chr 17: 48.96 – 48.97 MbChr 11: 95.92 – 95.92 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Gastric inhibitory polypeptide (GIP), also known as glucose-dependent insulinotropic polypeptide, is an inhibiting hormone of the secretin family of hormones.[5] While it is a weak inhibitor of gastric acid secretion, its main role, being an incretin, is to stimulate insulin secretion.[6]

GIP, along with glucagon-like peptide-1 (GLP-1), belongs to a class of molecules referred to as incretins,[7] which stimulate insulin release on oral food intake.

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000159224Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000014351Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Meier JJ, Nauck MA (2005). "Glucagon-like peptide 1(GLP-1) in biology and pathology". Diabetes/Metabolism Research and Reviews. 21 (2): 91–117. doi:10.1002/dmrr.538. PMID 15759282. S2CID 39547553.
  6. ^ Pederson RA, McIntosh CH (2016). "Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections". Journal of Diabetes Investigation. 7 (Suppl 1): 4–7. doi:10.1111/jdi.12480. PMC 4854497. PMID 27186348.
  7. ^ Efendic S, Portwood N (2004). "Overview of incretin hormones". Hormone and Metabolic Research. 36 (11–12): 742–6. doi:10.1055/s-2004-826157. PMID 15655702. S2CID 11634548.